| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spyre Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 95.5K | 15 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | 15 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 17 Jan 2025, 16:36 |
| SYRE | Spyre Therapeutics, Inc. | 01 Oct 2024 | 1 | $0 | 4 | Chief Medical Officer | 01 Oct 2024, 18:34 |
| SYRE | Spyre Therapeutics, Inc. | 01 Oct 2024 | 0 | $0 | 3 | Chief Medical Officer | 01 Oct 2024, 18:26 |